Compare RPRX & DLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPRX | DLTR |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4B | 25.1B |
| IPO Year | 2020 | 1996 |
| Metric | RPRX | DLTR |
|---|---|---|
| Price | $70.15 | $142.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 29 |
| Target Price | $72.00 | ★ $134.96 |
| AVG Volume (30 Days) | ★ 3.2M | 2.0M |
| Earning Date | 11-04-2026 | 11-24-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 144.33 |
| EPS | 1.03 | ★ 4.44 |
| Revenue | $2,378,193,000.00 | ★ $19,411,800,000.00 |
| Revenue This Year | $49.27 | $6.54 |
| Revenue Next Year | $9.11 | $6.03 |
| P/E Ratio | $67.27 | ★ $31.69 |
| Revenue Growth | 5.06 | ★ 10.43 |
| 52 Week Low | $37.31 | $85.88 |
| 52 Week High | $69.77 | $148.54 |
| Indicator | RPRX | DLTR |
|---|---|---|
| Relative Strength Index (RSI) | 77.70 | 62.40 |
| Support Level | $55.48 | $114.36 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.57 | 5.88 |
| MACD | 0.35 | 0.87 |
| Stochastic Oscillator | 95.66 | 77.61 |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2025, Dollar Tree generated over $19 billion in sales through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.